JPWO2022009698A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2022009698A5
JPWO2022009698A5 JP2022535021A JP2022535021A JPWO2022009698A5 JP WO2022009698 A5 JPWO2022009698 A5 JP WO2022009698A5 JP 2022535021 A JP2022535021 A JP 2022535021A JP 2022535021 A JP2022535021 A JP 2022535021A JP WO2022009698 A5 JPWO2022009698 A5 JP WO2022009698A5
Authority
JP
Japan
Prior art keywords
residue
pharma
acceptable salt
group
substituted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2022535021A
Other languages
English (en)
Japanese (ja)
Other versions
JPWO2022009698A1 (https=
JP7740715B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/JP2021/024125 external-priority patent/WO2022009698A1/ja
Publication of JPWO2022009698A1 publication Critical patent/JPWO2022009698A1/ja
Publication of JPWO2022009698A5 publication Critical patent/JPWO2022009698A5/ja
Application granted granted Critical
Publication of JP7740715B2 publication Critical patent/JP7740715B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2022535021A 2020-07-06 2021-06-25 ペプチドおよびそれを含む複合体 Active JP7740715B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2020116583 2020-07-06
JP2020116583 2020-07-06
PCT/JP2021/024125 WO2022009698A1 (ja) 2020-07-06 2021-06-25 ペプチドおよびそれを含む複合体

Publications (3)

Publication Number Publication Date
JPWO2022009698A1 JPWO2022009698A1 (https=) 2022-01-13
JPWO2022009698A5 true JPWO2022009698A5 (https=) 2024-07-02
JP7740715B2 JP7740715B2 (ja) 2025-09-17

Family

ID=79553070

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022535021A Active JP7740715B2 (ja) 2020-07-06 2021-06-25 ペプチドおよびそれを含む複合体

Country Status (2)

Country Link
JP (1) JP7740715B2 (https=)
WO (1) WO2022009698A1 (https=)

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1864996A1 (en) 2006-06-06 2007-12-12 Helmholtz-Zentrum für Infektionsforschung GmbH Peptide associated with rheumatic fever (PARF) and its use as a diagnostic marker.
WO2014119753A1 (ja) 2013-01-31 2014-08-07 学校法人 東京薬科大学 マイオスタチン阻害ペプチド
KR20160023669A (ko) 2013-06-26 2016-03-03 자이겐 인플라메이션 리미티드 다양한 질병의 치료를 위한 jnk 신호 전달 경로의 세포 투과성 펩타이드 억제자의 새로운 용도
GB201410507D0 (en) 2014-06-12 2014-07-30 Univ Bath Drug delivery enhancement agents
US11566047B2 (en) 2016-08-10 2023-01-31 Tokyo University Of Pharmacy & Life Sciences Peptide or pharmaceutically acceptable salt thereof, or prodrug thereof
JP2020059663A (ja) 2018-10-09 2020-04-16 学校法人東京薬科大学 ペプチドもしくはその薬学的に許容される塩、またはそれらのプロドラッグ

Similar Documents

Publication Publication Date Title
JP7823181B2 (ja) Ｈｒａｓおよびｎｒａｓに対して選択的なｋｒａｓ阻害作用を有する環状化合物
JP7411414B2 (ja) ペプチドの製造方法、及び塩基の処理方法
JP6703668B2 (ja) ペプチド合成方法
RU2017145921A (ru) Пептидомиметические макроциклы
JP2014507402A5 (https=)
JP2009537624A5 (https=)
CN108350009B (zh) 具有口服生物利用率的五氮杂大环状环络合物
JP2019043957A5 (https=)
JP2014530868A5 (https=)
FI3642340T3 (fi) Muunneltu l-asparaginaasi
JP2016515620A5 (https=)
CN115957296A (zh) 药物组合物
CA2975716A1 (en) Immunomodulators
JP2012500001A5 (https=)
JP2016521257A5 (https=)
JP2015110654A5 (https=)
JP6703669B2 (ja) リュープロレリンの製造方法
JP2016518351A5 (https=)
JP2019509280A5 (https=)
CA3182260A1 (en) Manufacture, formulation and dosing of apraglutide
JP2024543204A5 (https=)
JPWO2022009698A5 (https=)
TWI364291B (en) Peptidic vasopressin receptor agonists
JP2018519254A5 (https=)
JPS59170051A (ja) 薬理活性を有するトリペプチド誘導体